Related Experiment Video
Updated: May 7, 2026

Merkel Cell Polyomavirus Infection and Detection
Published on: February 7, 2019
Proliferative verrucous leukoplakia (PVL): a review of an elusive pathologic entity!
Ann M Gillenwater1, Nadarajah Vigneswaran, Hanadi Fatani
1Departments of *Head and Neck Surgery ‡Pathology §Medical Oncology, The University of Texas M.D. Anderson Cancer Center †Department of Diagnostic Sciences, The University of Texas School of Dentistry at Houston, Houston, TX.
Abstract:
Proliferative verrucous leukoplakia (PVL) is a rare less recognized form of oral leukoplakia. Patients with this condition represent a unique clinically and pathologically progressive characteristic from conventional leukoplakia. Because of the lack of defined pathologic lesions, identifying patients with the early diagnosis of PVL is challenging. This is largely due to the overlapping clinical and pathologic early features with conventional multifocal leukoplakia with dysplasia. The diagnosis can only be achieved through the keen clinical observation of the temporal progression in individual patients to verrucous and/or conventional squamous carcinoma. We present a brief view of the clinicopathologic and biological characteristics of PVL and discuss diagnosis, differential diagnosis, and management.
More Related Videos
Related Concept Videos
Abnormal Proliferation
Abnormal Proliferation
Proliferative Phase
Notably, the stratum basale, the basal layer of the endometrium, including the basal parts of the uterine glands, remains unaffected by menstruation. Stem cells in this layer undergo mitosis, regenerating the stratum functionalis and thickening the...
Cellular Adaptation IV: Dysplasia and Metaplasia
Graves Disease II: Pathophysiology
Peptic Ulcer Disease II: Pathophysiology
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

